USPSTF: Evidence Is Lacking for Oral Cancer Screenings

Share this content:
USPSTF Finds Evidence Is Lacking for Oral Cancer Screens
USPSTF Finds Evidence Is Lacking for Oral Cancer Screens

(HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) finds that there is currently not enough evidence to determine the benefits and harms of primary care screening of all adults for oral cancer, according to report it released April 8.

Researchers from the USPSTF reviewed the evidence to assess whether primary care professionals should screen their adult patients (age 18 years and older) for oral cancer. The primary screening test is a systematic clinical- or self-examination, including inspection and palpitation of the oral cavity. The Task Force concludes that the balance of benefits and harms cannot be determined, and an I statement has been issued, indicating insufficient evidence to produce a definitive recommendation. Noting that tobacco and alcohol use are risk factors for oral cancer, the Task Force recommends that clinicians screen adults for tobacco use, recommend against tobacco use, and encourage use of tobacco cessation interventions. Screening and behavioral counseling interventions in the primary care setting are also recommended to reduce alcohol misuse.

The draft Recommendation Statement is available for comment from April 9 to May 6, 2013.

"The evidence shows that it is difficult to detect oral cancer and that the evidence is not clear whether oral cancer screening improves long-term health outcomes among the general adult population or among high-risk groups," Task Force Member Jessica Herzstein, M.D., M.P.H., said in a statement ."We need more high-quality research on whether screening tests can accurately detect oral cancer and if screening adults for oral cancer in primary care settings improves health outcomes."

Draft Recommendation Statement
Comment on Recommendations

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs